Biomark Diagnostics Inc. (CSE:BUX)
Canada flag Canada · Delayed Price · Currency is CAD
0.2700
0.00 (0.00%)
Apr 1, 2025, 3:49 PM EST

Biomark Diagnostics Ratios and Metrics

Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2015 - 2019
Market Capitalization
192515163113
Upgrade
Market Cap Growth
-17.43%60.95%-1.62%-48.77%128.35%304.23%
Upgrade
Enterprise Value
212617173114
Upgrade
Last Close Price
0.270.300.210.230.420.18
Upgrade
PS Ratio
95.19152.12100.50356.91-50.91
Upgrade
PB Ratio
-13.44-40.73-13.42-24.67-386.98-30.52
Upgrade
EV/Sales Ratio
128.69161.35110.73393.16-51.81
Upgrade
Debt / Equity Ratio
-1.36-2.54-1.44-3.09-12.70-0.02
Upgrade
Asset Turnover
0.140.180.140.04-0.78
Upgrade
Quick Ratio
0.110.160.060.310.980.58
Upgrade
Current Ratio
0.110.160.080.331.000.58
Upgrade
Return on Assets (ROA)
-107.55%-117.29%-104.38%-66.20%-80.77%-220.06%
Upgrade
Return on Capital (ROIC)
-144.94%-148.56%-125.52%-71.12%-259.30%-
Upgrade
Earnings Yield
-9.80%-5.75%-11.94%-9.27%-3.57%-9.07%
Upgrade
FCF Yield
-4.44%-3.98%-5.96%-8.06%-2.64%-3.39%
Upgrade
Buyback Yield / Dilution
-709.75%-2.97%-6.22%-6.31%-2.82%-8.16%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.